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The antigen receptor repertoires of B- and T-cells form the basis of the adaptive immune
response.The repertoires should be sufficiently diverse to recognize all possible pathogens.
However, careful selection is needed to prevent responses to self or harmless antigens.
Limited antigen receptor repertoire diversity leads to immunodeficiency, whereas unse-
lected or misdirected repertoires can result in autoimmunity. The antigen receptor reper-
toire harbors information about abnormalities in many immunological disorders. Recent
developments in next generation sequencing allow the analysis of the antigen receptor
repertoire in much greater detail than ever before. Analyzing the antigen receptor repertoire
in patients with mutations in genes responsible for the generation of the antigen receptor
repertoire will give new insights into repertoire formation and selection. In this perspective,
we describe strategies and considerations for analysis of the naive and antigen-selected
B-cell repertoires in primary immunodeficiency patients with a focus on severe combined
immunodeficiency and common variable immunodeficiency.
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GENERATION OF THE T- AND B-CELL REPERTOIRE
V(D)J RECOMBINATION OF IMMUNOGLOBULIN AND T-CELL RECEPTOR
LOCI
The antigen receptor repertoire is defined as the total set of differ-
ent B-cell (BR) or T-cell receptors (TRs). The loci encoding these
receptors consist of multiple variable (V), diversity (D), and join-
ing (J) genes, which can be recombined via V(D)J recombination
to ensure the enormous diversity of the antigen receptors. V(D)J
recombination starts with induction of DNA double strand breaks
(DSBs) by the recombination-activating gene products RAG1 and
RAG2 between the coding element and the recombination signal
sequence (Figure 1A) (1). The DNA ends that contain the recom-
bination signal sequence, the so-called signal ends, are blunt DNA
ends, which can be ligated directly to form the signal joint. The
other ends (called the coding ends because they contain the coding
sequence of the Ig or TR gene) are blocked by a covalent phospho-
diester bond between the top and the bottom strand of the DNA.
These DNA hairpins are recognized, processed, and repaired by the
non-homologous end joining pathway (NHEJ) (Figure 1A). First,
the Ku70/80 heterodimer forms a ring around the DNA end that
can migrate into the DNA after initial binding. Ku70/80 bound to a
DNA end can then attract the DNA-dependent protein kinase cat-
alytic subunit (DNA-PKCS), which acquires protein kinase activity
upon DNA end binding. DNA-PKCS autophosphorylation induces
a conformational change in the DNA-bound complex of Ku70/80
and DNA-PKCS, collectively called the DNA-PK complex (2, 3).
After this conformational change,Artemis opens the DNA hairpins
(4, 5). If the ends are compatible, they can be ligated by ligase
IV, which forms a stable complex with XRCC4. XLF (XRCC4-
like factor), which has also been called “Cernunnos” (6). Before
ligation, non-templated (N) nucleotides can be inserted by termi-
nal deoxynucleotidyl transferase (TdT) or deleted via exonuclease
activity (Figure 1B) (7, 8). In addition to the NHEJ components,
several other factors are required to ensure efficient ligation of
so-called “difficult breaks” or “complex DNA damage.” Extensive
analysis of DSB repair kinetics revealed that these DSBs are mainly
localized to heterochromatin and require opening of the closed
chromatin structure in order to be repaired by NHEJ during the
G1 phase of the cell cycle or HR in the G2 phase. Chromatin
opening probably requires the initial phosphorylation of histone
H2AX, the ATM kinase, the MRE11/RAD50/Nijmegen breakage
syndrome (NBS)1 complex, and several enzymes necessary for
ubiquitin addition near the DSB, including RNF8 and RNF168
(9–11).
ANTIGEN RECEPTOR REPERTOIRE DIVERSITY
The total diversity of the unique TRs and BRs is the sum of com-
binational diversity based on the usage of different combinations
of V, (D), and J genes and junctional diversity due to nucleotide
deletions by exonuclease activity, non-templated (N) nucleotide
insertions that are introduced by the enzyme TdT, and the pres-
ence of palindromic (P) nucleotides that arise due to asymmetric
hairpin opening by Artemis (Figure 1B). In addition, combination
of the different chains (TRα and TRβ, TRγ and TRδ, or heavy
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FIGURE 1 | V(D)J recombination and B-cell development. (A) Schematic
overview of V(D)J recombination. DNA double strand breaks are introduced
by the RAG proteins, subsequently the DNA is processed and ligated by DNA
repair proteins from the NHEJ pathway. (B) Examples of V(D)J junctions
showing junctional diversity by nucleotides that are removed, non-templated
(N) nucleotides (blue) that are added, or presence of palindromic (P)
nucleotides (red). (C) The B-cell repertoire in peripheral blood can be divided
into the naive repertoire and the antigen-selected repertoire.
and light chains) also contributes to the overall diversity. The
immunoglobulin heavy chain (IGH) locus consist of 38–46 func-
tional VH, 25 DH, and 6 JH genes resulting in a combinational
diversity of >5.7× 103. In combination with the 200 possible Igκ
and 124 Igλ rearrangements, this results in a combinational diver-
sity of >1.8× 106. The total diversity of the BR is estimated to
result in a total BR repertoire of >1012.
STRATEGIES FOR B-CELL RECEPTOR REPERTOIRE ANALYSIS
NAIVE VERSUS ANTIGEN-SELECTED B-CELL RECEPTOR REPERTOIRE
The B-cell repertoire in peripheral blood can be divided into
the naive and antigen-selected repertoire (Figure 1C). The naive
repertoire, present in the transitional and naive mature B-cells,
has not encountered antigen and most closely resembles the ini-
tial repertoire formed by V(D)J recombination during precur-
sor B-cell differentiation. The naive repertoire can be regarded
as the end-stage product of V(D)J recombination. However, it
should be noted that by analyzing the naive repertoire only
those B-cells can be studied that reach the naive mature B-cell
stage. For studying disturbances in the V(D)J recombination
itself, it can be better to analyze complete V(D)J or incom-
plete DJ rearrangements in bone marrow (see below). Analysis
of the naive repertoire is preferably performed on DNA or RNA
obtained from sorted naive B-cells. Alternatively, IGM transcripts
can be analyzed in total RNA from peripheral blood mononu-
clear cells, of which only the unmutated sequences are taken
into account. Usually, sequences with 98% V region identity are
considered to be unmutated, since PCR and sequence errors might
occur (12).
The antigen-selected repertoire is the repertoire of cells that
encountered antigen, i.e., of memory B-cells. This repertoire is dif-
ferent from the naive repertoire, because it has undergone somatic
hypermutation (SHM) with subsequent selection in the germinal
center. The antigen-selected repertoire can be analyzed in sorted
memory B-cells or by sequencing of IGG and IGA transcripts from
RNA isolated from peripheral blood mononuclear cells.
In summary, for BR analysis, it is important to select and sort
the correct B-cell population depending on the research question.
QUALITATIVE CHARACTERISTICS OF THE REPERTOIRE
B-cell receptor repertoire encloses a lot of information about dif-
ferent processes of B-cell development. The V, D, and J usage
and junction composition, defined as the number of N- and P-
nucleotides, deletions, and the length of the complementarity
determining region (CDR)3 region, provide information about
the V(D)J recombination process.
Increased numbers of P-nucleotides (13) or deletions (14),
and decreased numbers of N-nucleotides are indications for a
NHEJ defect (15). In addition, skewing in the usage of V and
J genes can be observed, as is the case in the TR alpha reper-
toire in both Xlf knockout mice and an XLF-deficient patient
(16). Vera et al. hypothesized that the reduced thymocyte lifes-
pan does not allow the T-cells to undergo multiple waves of
VαJα rearrangements that can be needed for positive selection
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of the T-cells. Finally, several characteristics like increased usage
of certain auto-reactive VH genes, the charge of the CDR3,
and increased length of the CDR3 have been associated with
autoimmunity or impaired selection in patients with primary
immunodeficiencies (17–20). Patients with CD19 and CD40L
deficiency lack selection against long CDR3 and VH4-34, which
is known to encode intrinsically self-reactive cold agglutinin
antibodies that recognize carbohydrate antigens on erythrocytes
(20). Similarly, a patient with RAG deficiency and autoim-
munity has been described who lacked selection against these
inherited auto-reactive features and in addition had skewing of
the CDR3 repertoire for rearrangements with a certain CDR3
length (21).
PRODUCTIVE AND UNPRODUCTIVE IGH REPERTOIRE
The BR rearrangements can be amplified from DNA or from RNA.
Rearrangements amplified from RNA are mostly functional (also
called productive), which means that they code for a functional Ig
protein. Amplification of rearrangements from DNA allows analy-
sis of both productive and unproductive rearrangements, which
have not been selected. The latter is interesting because analy-
sis of productive and unproductive IGH rearrangements in naive
B-cells in controls shows that the productive rearrangements in
naive B-cells have a lower number of total N-nucleotides (13.8
versus 20.2 nt) consequently leading to a shorter CDR3 length
(Figure 2A). This might be explained by the fact that in bone mar-
row only B-cells are selected with a shorter CDR3 region. This
FIGURE 2 | Naive B-cell repertoire in control and CVID patients. The
naive B-cell repertoire was measured in 10 controls (C) and 18 CVID
patients, resulting in total 293,216 unique productive rearrangements for
control and 539,220 for CVID, and 127,261 unique unproductive
rearrangements for control and 305,402 for CVID. (A) Junction
characteristics of CVID patients are similar to controls. Average number
of total number of deletions, N-nucleotides, and P-nucleotides are
indicted per patient. (B) Similarly, the CDR3 length distribution (mean
with SEM) of IGH rearrangements is comparable to controls. In addition,
the frequency of amino acids in the CDR3 (median with range) is also
comparable. The positively charged amino acids are indicated in red and
the negatively charged in blue. (D) The diversity of the naive B-cell
repertoire in CVID patients is comparable to controls, however one
patient has a very restricted repertoire similar to patients with Nijmegen
breakage syndrome (NBS) and ataxia telangiectasia (AT). Data are shown
in box and whiskers (10–90 percentile). (E) The repertoire of this patient
remains very restricted over time. *p<0.05, **p<0.01, ***p<0.001,
****p<0.0001.
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indicates that analysis of unproductive rearrangements could give
additional information about the V(D)J recombination process
and selection.
The antigen-selected repertoire is mostly studied at RNA level,
by amplifying IGG, IGA, or IGE transcripts with primers located
in or upstream of the V gene and in the constant gene. In addition
to studying above mentioned characteristics of rearrangements,
and SHMs can be studied (20).
DIVERSITY OF THE REPERTOIRE
For several years, conventional cloning and sequencing were the
golden standard to study BR rearrangements. However, only small
numbers (20–100) of rearrangements could be studied, which give
a limited overview on the diversity of the total repertoire. There-
fore, the current next generation sequencing (NGS) approaches,
which enable to study thousands of rearrangements, give new
opportunities for studying the diversity of the repertoire. Although
the potential BR repertoire is estimated to be over 1012, this num-
ber exceeds the total number of different B-cells present in an
individual. When analyzing the diversity of the repertoire by NGS,
only a small fraction of the total B-cell population is analyzed.
When studying the antigen receptor repertoire diversity, it is of
great importance to take into account the number of B-cells that
was used to generate the repertoire data. If you start with 100,000
B-cells, one cannot expect to find more than 100,000 different pro-
ductive rearrangements. Since every B-cell contains only one DNA
copy of a productive rearrangement, the total number of produc-
tive rearrangement can be estimated when using a fixed DNA input
of sorted B-cells. Every cell contains around 6 pg of DNA, so 100 ng
DNA represent approximately 16,667 cells, which also equals the
number of productive rearrangements that can be expected. In
general, every B-cell contains only one productive rearrangement,
however multiple B-cells with the same rearrangements can be
present in the B-cell pool being studied.
When using RNA for the repertoire analysis it is difficult to esti-
mate the number of cells, because every B-cell contains multiple
RNA copies of the same rearrangement, and plasma cells con-
tain more RNA copies of the rearrangement compared to other
B-cell subsets. So, when multiple copies of the same rearrange-
ment are found, these can be derived from the same B-cell, two
independent B-cells, or they can be a technical duplication. One
should therefore be careful interpreting the data, and for reper-
toire calculations, it is best to only take the unique productive
rearrangements in to account, unless randomly barcoded primers
to identify individual B-cells are used (22).
In literature, different methods for diversity calculations are
used. Species richness and Shannon entropy are frequently used
methods (23,24). The Species richness takes into account the num-
ber of different rearrangements in a sample, whereas the Shannon
entropy also takes the frequency of the rearrangement into account
(23). The latter methods are usually performed on rearrangements
derived from an individual PCR amplification. Boyd et al. used
a slightly different method in which occurrences of rearrange-
ments between six individual PCR within the same individual
was measured (25). These occurrences, also called coincidences,
could only be derived from clonally related B-cells. Immuno-
competent individuals should have little coincidences since they
have a diverse repertoire, while immunocompromised individu-
als are likely to have more coincidences since they have a more
restricted repertoire.
B-CELL RECEPTOR REPERTOIRE ANALYSIS IN SCID
In patients with primary immunodeficiencies, antigen receptor
repertoire formation or selection can be disturbed, resulting in
restricted antigen receptor repertoire diversity. Depending on the
genetic defect, this can result in severe immunodeficiency as is the
case in severe combined immunodeficiency (SCID) patients with
defects in RAG1/RAG2 or in components of the NHEJ pathway
with severely impaired V(D)J recombination (6, 14, 26–29). These
genetic defects not only result in a quantitative V(D)J recom-
bination defect, but also in a qualitative defect. Because of the
qualitative V(D)J recombination defects, there are no peripheral
B-cells or the number of B-cells is too low for reliable analysis. In
this case, the repertoire can be studied by analyzing incomplete
or complete BR rearrangements in bone marrow-derived precur-
sor B-cells. NHEJ defects leads to aberrant formation of V(D)J
junctions and greatly impact junctional diversity, which implies
that NHEJ defects cause a quantitative and qualitative antigen
receptor repertoire defect. For example, mutations in Artemis and
DNA-PKcs (13, 29), which affect hairpin opening, result in a sig-
nificant increase in the number of P-nucleotides, whereas defects
in XRCC4 result in significantly reduced numbers of N-nucleotide
insertions (15).
Also, other genetic defects, like ATM and NBS deficiency, result
in reduced diversity of the naive B-cell repertoire. These proteins
are not directly involved in the V(D)J recombination process itself,
but are important for sensing of the DNA DSBs and for keeping
the two DNA ends together during V(D)J recombination. As the
result of less efficient V(D)J recombination, patients have reduced
numbers of naive B-cells in the periphery, which can in addi-
tion show an increased proliferation history which results in even
more restriction of the repertoire. This is what we have shown
in patients with mutations in ATM causing ataxia telangiectasia
(AT), which is involved in DSB sensing and juxtaposition of DNA
ends, impair antigen receptor repertoire diversity (30). Similar
observations have been done in patients with NBS (31).
B-CELL RECEPTOR REPERTOIRE ANALYSIS IN CVID
NO QUALITATIVE DEFECT IN THE NAIVE IGH REPERTOIRE OF CVID
PATIENTS
Common variable immunodeficiency (CVID) is the most com-
mon primary antibody deficiency characterized by hypogam-
maglobulinemia and poor response to vaccination resulting in
infections and in some patients to non-infectious complications
including autoimmunity, lymphoproliferative disease, malignan-
cies, and granulomas. In the majority of patients (95%), the genetic
defect is unknown, but several studies have demonstrated defects
in B-cell differentiation. Therefore, CVID patients could have a
restricted BR repertoire underlying the disease.
Driessen et al. showed that a subgroup of CVID patients also
have a reduced number of naive B-cells, with an increased prolif-
eration history, like the AT and NBS patients. (32) Therefore, we
hypothesized that a subgroup of patients with CVID might have
a reduction in the diversity of the naive IGH repertoire, possibly
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caused by less efficient V(D)J recombination. We studied the naive
IGH repertoire in 18 patients described by Driessen et al. (32) and
10 healthy controls. We sorted naive B-cells and amplified the
VH–JH junctions in six independent PCRs using 100 ng DNA per
PCR. For the analysis of the qualitative parameters, we combined
the rearrangements of all six individual PCRs and selected the pro-
ductive or unproductive unique rearrangements based on the V
and J gene and the amino acid sequence of the CDR3.
All of the qualitative parameters we studied were similar to
healthy controls in this group of CVID patients. The compo-
sition of the junctions in both productive and unproductive
rearrangements was normal (Figure 2A). The only differences
were a slightly higher number of N-nucleotides (average differ-
ence of 0.7 nucleotides) in productive rearrangements, and a
very small decrease (on average 0.04 nucleotides) in the num-
ber of P-nucleotides in unproductive rearrangements. However,
this did not result in a shorter CDR3 length (Figure 2B). Sim-
ilar to controls, the productive rearrangements had significantly
less deletions and N-nucleotide insertions, indicating selection for
shorter CDR3 length. Furthermore, the CDR3 length distribution
and composition of hydrophilic and hydrophobic amino acids was
also similar to controls (Figures 2B,C). These data suggest that
these CVID patients do not have a qualitative defect in the naive
repertoire.
DIVERSITY OF THE NAIVE IGH REPERTOIRE IS NORMAL IN MOST CVID
PATIENTS
To measure the diversity of the naive IGH repertoire, we used the
method proposed by Boyd et al. (25). Based on the occurrence
of rearrangements between six independent PCRs, the diversity
of the repertoire can be calculated. We expressed the diversity of
the repertoire in a diversity score, in which a low value indicate
a restricted repertoire and a high value represents a more diverse
repertoire. Both in the control as in the CVID patients, there is
some spread in the diversity of the repertoire (Figure 2D). How-
ever, one CVID patient clearly had a more restricted repertoire
that the controls. This repertoire was as restricted as patients with
NBS and AT deficiency (Figure 2D). To assess if this reduction
in the repertoire is stable over time, the repertoire was analyzed
at a second time point 7 years later (Figure 2E). At both 46 and
53 years of age, this patient had a very restricted repertoire. At the
second time point, there were even 10 rearrangements present in
all individual PCRs, indicating that in the small sample of blood
that we took, at least six B-cells had the same IGH rearrange-
ment. Interestingly, this patient has a family history of breast
cancer indicative for a possible DNA repair defect. These data
show that patients with a restricted repertoire can be identified
using this method, however, most CVID patients have a very
diverse naive repertoire. Based on the B-cell patterns identified
by Driessen et al., it is expected that most of the CVID patients
will have problems after the naive B-cell stage. It will therefore
be very interesting to also study the antigen-selected repertoire in
patients with CVID.
FUTURE PERSPECTIVES
Developments in NGS give possibilities to study the antigen recep-
tor repertoire of patients at a very detailed level than ever before.
Different strategies can be followed to address many research ques-
tions related to the pathophysiology of primary immunodeficiency
(PID). In this perspective, we focused on SCID and CVID, but it
has already been proven valuable for many other PIDs (33). The
next challenge will be linking antigen receptor repertoire data to
antigen reactivity and specificity, which might in future be linked
to specific clinical features.
METHODS
REPERTOIRE ANALYSIS USING NEXT GENERATION SEQUENCING
Naive B-cells were sorted from peripheral blood from 18 CVID
patients and 10 healthy controls. DNA was isolated using direct
lysis and IGH rearrangements were amplified and sequenced using
Roche 454 sequencing as previously described (30). In short, IGH
rearrangements were amplified from a multiplex PCR using the
forward VH1-6 FR1 and reverse JH consensus BIOMED-2 primers
(34). PCR products were purified by gel extraction (Qiagen,Valen-
cia, CA, USA) and Agencourt AMPure XP beads (Beckman Coul-
ter). Subsequently, the PCR concentration was measured using
the Quant-it Picogreen dsDNA assay (Invitrogen, Carlsbad, CA,
USA). The purified PCR products were sequenced on the 454
GS junior instrument according the manufacturer’s recommen-
dations. Sequences were demultiplexed based on their multiplex
identifier sequence and trimmed using the IGGalaxy tool (35).
Fasta files were uploaded in IMGT/High-V-Quest (36), and sub-
sequently, the IMGT output files were analyzed in the IGGalaxy
tool (35). Information on junction characteristics, CDR3 length,
and composition were extracted from the data provided by IMGT.
The repertoire diversity score was calculated by dividing 1 to the
clonality score, which is given by the IGGalaxy tool and is based
on the calculation of Boyd et al. (25).
STATISTICS
Significance differences were calculated using the two-tailed
Mann–Whitney test in the GraphPad Prism program (GraphPad
Software, Inc.).
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